You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
22 December 2006
UCB S.A.: UCB announces positive results from two new phase III studies in rheumatoid arthritis and provides update on the status of US approval for CIMZIA(TM) in the treatment of Crohn’s disease